Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G antigen, family D pseudogene (ENSG00000186678; alias LOC101060042, AL590240.1) is annotated in the human genome as a non-coding pseudogene related to the Rh blood group family[1]. Pseudogenes like this do not encode active proteins and do not produce functional molecular targets relevant to drug discovery or therapeutic modulation. They typically arise from duplication or mutation of active genes and lack biological activity. There is no evidence that this gene plays any role in well-characterized molecular families such as receptors, enzymes, transporters, or transcription factors. No disease associations, actionable functions, or biomarker utility have been reported, and it is not considered a therapeutic target. This entry is thus not suitable for drug targeting or therapeutic intervention, and may be misleading if presumed to be a functional gene or protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G antigen, family D pseudogene.